Holders

BRIDGEBIO PHARMA INC

Q1 2026 13F holders

CUSIP
10806XAB8
Type
Debt
Class
NOTE 2.500% 3/1
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Principal Option type